National Observatory on the therapeutic management in general practice of patients aged 65 and over with type 2 diabetes, chronic pain or atrial fibrillation

{"level_sex_clusion_I":[{"value":"Male","concept":{"vocab":"MeSH","vocabURI":"D008297"}},{"value":"Female","concept":{"vocab":"MeSH","vocabURI":"D005260"}}],"level_age_clusion_I":[{"value":"Aged (65 to 79 years)","concept":{"vocab":"MeSH","vocabURI":"D000368"}},{"value":"Aged, 80 and over (80 years and more)","concept":{"vocab":"MeSH","vocabURI":"D000369"}}],"level_type_clusion_I":"Patients population","level_type_clusion_other":"","clusion_I":"▪ Man or woman ages 65 years and older residing in metropolitan ▪ Affiliated with a social security scheme or beneficiary of an equivalent scheme • Accepting to participate in the study and who have signed the consent form ▪ Having type-2 diabetes treated by oral diabetes medication and/or injectable diabetes medication (for the Diabetes observatory) ▪ Having or who has had in the 12 months preceding inclusion, a documented atrial fibrillation (AF) (by ECG or Holter ECG) regardless of the rhythm on the day of inclusion (for the Atrial Fibrillation observatory) ▪ Having a pain that has been evolving for more than 3 months, requiring care (for the Chronic Pain observatory)","clusion_E":""}